enVVeno Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVNO and other ETFs, options, and stocks.

About NVNO

enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. 

CEO
Robert Andrew Berman
CEORobert Andrew Berman
Employees
37
Employees37
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1999
Founded1999
Employees
37
Employees37

NVNO Key Statistics

Market cap
87.04M
Market cap87.04M
Price-Earnings ratio
-4.25
Price-Earnings ratio-4.25
Dividend yield
Dividend yield
Average volume
138.90K
Average volume138.90K
High today
$5.51
High today$5.51
Low today
$4.85
Low today$4.85
Open price
$5.32
Open price$5.32
Volume
359.02K
Volume359.02K
52 Week high
$6.13
52 Week high$6.13
52 Week low
$2.03
52 Week low$2.03

People also own

Based on the portfolios of people who own NVNO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.